Ameriprise
SGHT icon

Ameriprise’s Sight Sciences SGHT Stock Holding History

Ameriprise’s Portfolio SGHT Stock Details SGHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-64,876
Closed -$567K – 3995
2023
Q1 		$567K Sell
64,876
-10
-0% -$111 ﹤0.01% 3382
2022
Q4 		$792K Buy
+64,886
New +$617K ﹤0.01% 3231
2022
Q3 		– Sell
-44,840
Closed -$403K – 4026
2022
Q2 		$403K Buy
44,840
+3,004
+7% +$26.4K ﹤0.01% 3463
2022
Q1 		$483K Buy
41,836
+4,725
+13% +$72.7K ﹤0.01% 3500
2021
Q4 		$652K Sell
37,111
-1,457
-4% -$32K ﹤0.01% 3431
2021
Q3 		$875K Buy
+38,568
New +$1.27M ﹤0.01% 3218

Other funds holding SGHT

DCP
D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return
KL
KCK Ltd Hamilton, Bermuda $15.1M AUM 30.14% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise's SGHT Position: Q2 2023 in Review

Ameriprise sold out of Sight Sciences (SGHT) in Q2 2023, closing a stake of 64,876 shares — an estimated $567K sold.

Ameriprise first reported a position in SGHT in Q3 2021 and held it in 6 quarters. The position peaked at $875K in Q3 2021. 73 funds tracked by Wall St. Rank hold SGHT as of Q2 2023.

  • Ameriprise reported no remaining Sight Sciences position as of Q2 2023 after selling out during the quarter.
  • Ameriprise sold 64,876 Sight Sciences shares in Q2 2023, an estimated $567K.
  • Ameriprise first reported a position in Sight Sciences in Q3 2021 and held it in 6 quarters.
  • Ameriprise's Sight Sciences position peaked at $875K in Q3 2021.
  • 73 funds tracked by Wall St. Rank held Sight Sciences as of Q2 2023.

Based on Ameriprise's 13F filing for Q2 2023, filed 14 Aug 2023.